(0.11%) 5 024.06 points
(0.19%) 37 976 points
(0.29%) 15 651 points
(-0.08%) $78.94
(3.42%) $1.998
(-0.36%) $2 302.70
(-0.14%) $26.71
(0.12%) $956.05
(0.38%) $0.937
(0.52%) $11.09
(0.40%) $0.802
(-1.20%) $92.14
Quarter results today
(amc 2024-05-02)
Expected move: +/- 6.61%
@ $36.78
Išleistas: 1 geg. 2024 @ 22:39
Grąža: -4.46%
Ankstesnis signalas: geg. 1 - 22:01
Ankstesnis signalas:
Grąža: -1.20 %
Live Chart Being Loaded With Signals
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 358 578 |
Vidutinė apimtis | 1.79M |
Rinkos kapitalizacija | 2.27B |
EPS | $0 ( 2024-05-01 ) |
Kita pelno data | ( $0 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.24 |
ATR14 | $2.42 (6.87%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Carpenter Rick | Buy | 405 | Common Stock |
2024-03-15 | Carpenter Rick | Sell | 145 | Common Stock |
2024-03-15 | Carpenter Rick | Sell | 405 | Restricted Stock Unit |
2024-02-27 | Morrison Susan | Buy | 407 | Common Stock |
2024-02-27 | Morrison Susan | Sell | 113 | Common Stock |
INSIDER POWER |
---|
62.95 |
Last 100 transactions |
Buy: 113 075 | Sell: 24 727 |
Tūris Koreliacija
Tandem Diabetes Care Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
GAINL | 0.983 |
TDAC | 0.927 |
ISNS | 0.883 |
APOP | 0.88 |
RMRM | 0.851 |
SQBG | 0.844 |
YMAB | 0.842 |
NTEC | 0.82 |
BROG | 0.819 |
HBNC | 0.807 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Tandem Diabetes Care Inc Koreliacija - Valiuta/Žaliavos
Tandem Diabetes Care Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $747.72M |
Bruto pelnas: | $367.69M (49.17 %) |
EPS: | $-3.43 |
FY | 2023 |
Pajamos: | $747.72M |
Bruto pelnas: | $367.69M (49.17 %) |
EPS: | $-3.43 |
FY | 2022 |
Pajamos: | $801.22M |
Bruto pelnas: | $412.99M (51.54 %) |
EPS: | $-1.470 |
FY | 2021 |
Pajamos: | $702.80M |
Bruto pelnas: | $376.22M (53.53 %) |
EPS: | $0.260 |
Financial Reports:
No articles found.
Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.